Akero Therapeutics Inc’s filing revealed that its Officer Jonathan Young acquired Company’s shares for reported $1.95 million on Jan 02 ’25. In the deal valued at $27.82 per share,70,000 shares were bought.
Then, Lamy Patrick sold 1,000 shares, generating $29,130 in total proceeds. Upon selling the shares at $29.13, the Senior VP, Commercial Strategy now owns 34,258 shares.
Before that, Yale Catriona sold 9,074 shares. Akero Therapeutics Inc shares valued at $264,117 were divested by the Chief Development Officer at a price of $29.11 per share. As a result of the transaction, Yale Catriona now holds 95,648 shares, worth roughly $2.7 million.
Citigroup initiated its Akero Therapeutics Inc [AKRO] rating to a Buy in a research note published on November 18, 2024; the price target was $65. Cantor Fitzgerald began covering AKRO with “an Overweight” recommendation on September 19, 2023. UBS started covering the stock on August 28, 2023. It rated AKRO as “a Buy”.
Price Performance Review of AKRO
On Friday, Akero Therapeutics Inc [NASDAQ:AKRO] saw its stock jump 0.57% to $28.24. Over the last five days, the stock has lost -2.25%. Akero Therapeutics Inc shares have risen nearly 1.51% since the year began. Nevertheless, the stocks have risen 27.15% over the past one year. While a 52-week high of $37.00 was reached on 01/03/25, a 52-week low of $15.32 was recorded on 01/02/25. SMA at 50 days reached $30.50, while 200 days put it at $25.93.
Levels Of Support And Resistance For AKRO Stock
The 24-hour chart illustrates a support level at 27.83, which if violated will result in even more drops to 27.41. On the upside, there is a resistance level at 28.69. A further resistance level may holdings at 29.14. The Relative Strength Index (RSI) on the 14-day chart is 42.96, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.62, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 78.08%. Stochastics %K at 17.16% indicates the stock is a buying.
How much short interest is there in Akero Therapeutics Inc?
A steep rise in short interest was recorded in Akero Therapeutics Inc stocks on 2024-12-13, dropping by -0.33 million shares to a total of 3.3 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-15 was 3.62 million shares. There was a decline of -9.89%, which implies that there is a negative sentiment for the stock.
